About
Profile
Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to treat rare and underserved eye diseases. Our breakthrough modifier gene therapy platform has the potential to treat multiple ret
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
OCGN
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Ocugen says EU backs a U.S. trial for gene therapy
- Ocugen stock gains after FDA nod to initiate Phase 3 trial of gene therapy candidate
- Ocugen advances Phase 1/2 trial for eye disease candidate
- Ocugen slips as accounting errors force restatements
- HUT, CXAI and BDRX among pre-market losers
- Ocugen shares make gains after US court dismisses class action lawsuits
- Biggest stock movers today: TSLA, DWAC, FDX, NKE, and more
- Ocugen hits a 52-week high after decision to lower quorum requirement
- OCGN, MTC and KAVL among mid-day movers
- Ocugen promotes Huma Qamar as Chief Medical Officer
- Ocugen CEO to present at Abu Dhabi Family Office Summit on Friday
- Ocugen, Community Health Systems among healthcare movers
- EFOI, CNEY and ATCH among pre-market losers
- OCGN, NEO and FRSX are among pre market gainers
- Bank of America more favorable on SMID-cap biotechs into 2024
- Ocugen GAAP EPS of -$0.06 beats by $0.01
- Ocugen Q3 2023 Earnings Preview
- Notable earnings before Thursday's open
- Ocugen mucosal vaccine selected for U.S. COVID vaccine initiative
- Ocugen Retinitis Pigmentosa asset bolstered by new data
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| May 26, 2023 | 0.46 | 0.45 |
0.47
|
0.44
|
12.2M | 2.22% | ||||
| May 25, 2023 | 0.45 | 0.48 |
0.49
|
0.45
|
14.9M | -4.26% | ||||
| May 24, 2023 | 0.47 | 0.55 |
0.57
|
0.44
|
44.9M | -34.72% | ||||
| May 23, 2023 | 0.72 | 0.72 |
0.78
|
0.72
|
9.0M | 0% | ||||
| May 22, 2023 | 0.72 | 0.67 |
0.73
|
0.66
|
8.5M | 7.46% | ||||
| May 19, 2023 | 0.67 | 0.66 |
0.68
|
0.65
|
6.8M | 1.52% | ||||
| May 18, 2023 | 0.66 | 0.7 |
0.7
|
0.63
|
10.4M | -4.35% | ||||
| May 17, 2023 | 0.69 | 0.7 |
0.7
|
0.68
|
2.4M | 0% | ||||
| May 16, 2023 | 0.69 | 0.7 |
0.75
|
0.68
|
5.9M | -5.48% | ||||
| May 15, 2023 | 0.73 | 0.68 |
0.74
|
0.67
|
6.6M | 7.35% | ||||
| May 12, 2023 | 0.68 | 0.71 |
0.71
|
0.66
|
5.3M | -2.86% | ||||
| May 11, 2023 | 0.7 | 0.75 |
0.76
|
0.7
|
5.8M | -6.67% | ||||
| May 10, 2023 | 0.75 | 0.74 |
0.77
|
0.73
|
5.4M | 2.74% | ||||
| May 9, 2023 | 0.73 | 0.72 |
0.74
|
0.7
|
5.2M | 1.39% | ||||
| May 8, 2023 | 0.72 | 0.71 |
0.75
|
0.71
|
7.9M | 2.86% | ||||
| May 5, 2023 | 0.7 | 0.72 |
0.72
|
0.69
|
5.1M | 1.45% | ||||
| May 4, 2023 | 0.69 | 0.7 |
0.72
|
0.68
|
4.2M | -1.43% | ||||
| May 3, 2023 | 0.7 | 0.68 |
0.72
|
0.68
|
5.4M | 2.94% | ||||
| May 2, 2023 | 0.68 | 0.7 |
0.71
|
0.67
|
5.5M | -2.86% | ||||
| May 1, 2023 | 0.7 | 0.72 |
0.72
|
0.7
|
3.6M | -1.41% | ||||
| Apr 28, 2023 | 0.71 | 0.71 |
0.73
|
0.69
|
5.4M | 0% | ||||
| Apr 27, 2023 | 0.71 | 0.73 |
0.75
|
0.7
|
5.1M | -1.39% | ||||
| Apr 26, 2023 | 0.72 | 0.71 |
0.73
|
0.68
|
9.6M | 1.41% | ||||
| Apr 25, 2023 | 0.71 | 0.72 |
0.74
|
0.7
|
8.6M | -1.39% | ||||
| Apr 24, 2023 | 0.72 | 0.8 |
0.81
|
0.7
|
7.5M | -8.86% | ||||
| Apr 21, 2023 | 0.79 | 0.82 |
0.84
|
0.78
|
4.0M | -3.66% | ||||
| Apr 20, 2023 | 0.82 | 0.86 |
0.87
|
0.81
|
3.7M | -5.75% | ||||
| Apr 19, 2023 | 0.87 | 0.85 |
0.89
|
0.83
|
3.8M | 0% | ||||
| Apr 18, 2023 | 0.87 | 0.83 |
0.89
|
0.81
|
6.3M | 6.10% | ||||
| Apr 17, 2023 | 0.82 | 0.81 |
0.82
|
0.79
|
2.1M | 2.50% | ||||
| Apr 14, 2023 | 0.8 | 0.87 |
0.87
|
0.79
|
4.9M | -5.88% | ||||
| Apr 13, 2023 | 0.85 | 0.81 |
0.87
|
0.8
|
4.0M | 7.59% | ||||
| Apr 12, 2023 | 0.79 | 0.82 |
0.83
|
0.78
|
2.5M | -2.47% | ||||
| Apr 11, 2023 | 0.81 | 0.76 |
0.81
|
0.75
|
5.9M | 8% | ||||
| Apr 10, 2023 | 0.75 | 0.79 |
0.8
|
0.75
|
3.8M | -3.85% | ||||
| Apr 6, 2023 | 0.78 | 0.78 |
0.81
|
0.75
|
2.6M | 2.63% | ||||
| Apr 5, 2023 | 0.76 | 0.82 |
0.82
|
0.76
|
3.5M | -6.17% | ||||
| Apr 4, 2023 | 0.81 | 0.87 |
0.87
|
0.81
|
3.5M | -5.81% | ||||
| Apr 3, 2023 | 0.86 | 0.86 |
0.89
|
0.86
|
2.7M | 1.18% | ||||
| Mar 31, 2023 | 0.85 | 0.84 |
0.87
|
0.82
|
3.1M | 3.66% | ||||
| Mar 30, 2023 | 0.82 | 0.89 |
0.89
|
0.82
|
4.3M | -6.82% | ||||
| Mar 29, 2023 | 0.88 | 0.85 |
0.9
|
0.84
|
4.3M | 6.02% | ||||
| Mar 28, 2023 | 0.83 | 0.9 |
0.91
|
0.83
|
4.5M | -6.74% | ||||
| Mar 27, 2023 | 0.89 | 0.94 |
0.94
|
0.88
|
4.6M | -3.26% | ||||
| Mar 24, 2023 | 0.92 | 0.87 |
0.94
|
0.87
|
4.1M | 4.55% | ||||
| Mar 23, 2023 | 0.88 | 0.92 |
0.94
|
0.86
|
5.1M | -3.3% | ||||
| Mar 22, 2023 | 0.91 | 0.97 |
0.97
|
0.89
|
7.8M | -4.21% | ||||
| Mar 21, 2023 | 0.95 | 0.94 |
0.96
|
0.93
|
7.4M | 0% | ||||
| Mar 20, 2023 | 0.95 | 0.97 |
0.97
|
0.91
|
9.9M | -2.06% | ||||
| Mar 17, 2023 | 0.97 | 1 |
1.05
|
0.95
|
37.5M | -3.96% | ||||
| Mar 16, 2023 | 1.01 | 0.91 |
1.02
|
0.9
|
11.3M | 9.78% | ||||
| Mar 15, 2023 | 0.92 | 0.92 |
0.94
|
0.9
|
10.6M | -2.13% | ||||
| Mar 14, 2023 | 0.94 | 0.91 |
0.97
|
0.91
|
6.3M | 3.30% | ||||
| Mar 13, 2023 | 0.91 | 0.89 |
0.96
|
0.89
|
6.0M | -1.09% | ||||
| Mar 10, 2023 | 0.92 | 0.89 |
0.94
|
0.85
|
10.0M | 3.37% | ||||
| Mar 9, 2023 | 0.89 | 0.95 |
0.96
|
0.88
|
9.0M | -5.32% | ||||
| Mar 8, 2023 | 0.94 | 0.97 |
0.99
|
0.91
|
11.7M | -3.09% | ||||
| Mar 7, 2023 | 0.97 | 0.98 |
1.01
|
0.96
|
6.8M | -1.02% | ||||
| Mar 6, 2023 | 0.98 | 1.02 |
1.04
|
0.97
|
5.8M | -5.77% | ||||
| Mar 3, 2023 | 1.04 | 1.01 |
1.04
|
1
|
4.8M | 0% | ||||